Gaziza Azhmagievna Smagulova

Gaziza Azhmagievna Smagulova

Auto-generated profile, based on publicly available information

Gaziza Azhmagievna Smagulova

West Kazakhstan Marat Ospanov Medical University; Aktobe, Kazakhstan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
NANurgul Ablakimova
Nurgul Ablakimova
GSGaziza A. Smagulova
Gaziza A. Smagulova
Svetlana RachinaSvetlana Rachina
Svetlana Rachina
AMAigul Z. Mussina
Aigul Z. Mussina
Afshin ZareAfshin Zare
Afshin Zare
Amin TamadonAmin Tamadon
Amin Tamadon
Antimicrobial resistance (AMR) is a pressing global concern, posing significant challenges to the effective treatment of infections, including pneumonia. This bibliometric analysis aims to investigate the research output on AMR among pneumonia pathogens from 2013 to 2023. Data were extracted from the Web of Science Core Collection (WOS-CC) using an inclusive search strategy. The analysis included 152 relevant studies published in 99 different sources, involving 988 authors and yielding an average of 16.33 citations per document over the past decade. The findings reveal a notable increase in research on AMR among pneumonia pathogens, indicating a growing awareness of this critical issue. Collaborative studies were prevalent, with the majority of authors engaging in joint research efforts. Bradford’s Law identified twelve core journals that were instrumental in disseminating research in this field, with “Medicine” emerging as the most prolific journal. The USA and China emerged as the leading contributors, while Germany displayed a strong inclination towards collaborative research. Intermountain Medical Center, Saitama Medical University, and Udice-French Research Universities were the most productive institutions, and Yayan J. and Rasche K. were the top authors. Furthermore, the analysis identified commonly encountered microorganisms such as Acinetobacter baumanii and Klebsiella pneumoniae in the context of AMR. Time-based analysis of keywords highlighted the significance of terms like “community-acquired pneumonia” and “ventilator-associated pneumonia”. Overall, this comprehensive study sheds light on the global research landscape of AMR among pneumonia pathogens. The insights gained from this analysis are essential for guiding future research priorities and collaborative efforts to combat AMR effectively and improve treatment outcomes for pneumonia and related infections. As the frequency of reports concerning resistance among pneumonia pathogens, notably A. baumannii and K. pneumoniae, continues to rise, there is an immediate requirement for pharmaceutical manufacturers and healthcare providers to respond proactively and ready themselves for the forthcoming implications of this matter. It also underscores the importance of knowledge dissemination and evidence-based interventions to address this growing public health challenge. However, the study acknowledges the limitations associated with using a single publication database and encourages the inclusion of data from other sources in future research.

8 August 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
NANurgul Ablakimova
Nurgul Ablakimova
AMAigul Z. Mussina
Aigul Z. Mussina
GSGaziza A. Smagulova
Gaziza A. Smagulova
Svetlana RachinaSvetlana Rachina
Svetlana Rachina
MKMeirambek S. Kurmangazin
Meirambek S. Kurmangazin
FRFarhad Rahmanifar
Farhad Rahmanifar
This cross-sectional study investigated the microbial landscape and antibiotic-resistance patterns in patients with bacterial pneumonia, with a focus on the impact of COVID-19. Sputum samples from individuals with bacterial pneumonia, including coronavirus disease 2019-positive polymerase chain reaction (COVID-19-PCR+), COVID-19-PCR− and non-COVID-19 patients, were analyzed. Surprisingly, the classic etiological factor of bacterial pneumonia, Streptococcus pneumoniae, was rarely isolated from the sputum samples. Furthermore, the frequency of multidrug-resistant pathogens was found to be higher in non-COVID-19 patients, highlighting the potential impact of the pandemic on antimicrobial resistance. Strains obtained from COVID-19-PCR+ patients exhibited significant resistance to commonly used antibiotics, including fluoroquinolones and cephalosporins. Notably, the ESKAPE pathogens, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae, and Enterobacter aerogenes, were identified among the isolated microorganisms. Our findings underscore the urgent need for infection control measures and responsible antibiotic use in healthcare settings, as well as the importance of enhancing pneumonia diagnostics and implementing standardized laboratory protocols.

6 November 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
ABAigerim Aldiyarovna Balapasheva
Aigerim Aldiyarovna Balapasheva
GSGaziza A. Smagulova
Gaziza A. Smagulova
AMAigul Z. Mussina
Aigul Z. Mussina
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
ZNZhansulu Zh. Nurgaliyeva
Zhansulu Zh. Nurgaliyeva
In the context of the global spread of Coronavirus Disease 2019 (COVID-19), the issue of evaluating and optimizing the use of antibacterial drugs becomes especially relevant. The coronavirus pandemic has provided a unique opportunity to study the dynamics of the consumption of antibacterial agents and their impact on public health. The rational use of antibiotics is a key aspect of the fight against antimicrobial resistance, which makes this study particularly important. The aim of this study was to assess changes in the consumption of antibacterial drugs among patients hospitalized with COVID-19 during the peak of the 2020 pandemic and compare them with data from 2019 prior to the pandemic. This study collated data on antibacterial drug consumption in a regional hospital in Aktobe, which served a large population of patients during the pandemic. A pharmacoepidemiological study was conducted using the Anatomical Therapeutic Chemical (ATC)/Defined Daily Dose (DDD) methodology. The pharmacoepidemiological study using the international ATC/DDD methodology revealed a concerning pattern of irrational consumption of antibacterial drugs, including cephalosporins, azalides, second-generation fluoroquinolones, and systemic aminoglycosides in Aktobe. Among antibacterial drugs during the pandemic, the most significant increase in consumption was from the group of cephalosporins (19,043 DDD/100 bed-days). The share of their consumption was 35.4% of the total consumption of antibacterial drugs. Pharmacoepidemiological studies using the international methodology ATC/DDD showed an alarming picture of irrational consumption of antibacterial drugs of the group of cephalosporins, azalides, fluoroquinolones, and aminoglycosides in Aktobe, and, in this case, excessive use of the identified antibiotics raises concerns about the possibility of increasing the problem of resistance to microbes.

1 June 2020 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
Saule K. BalmagambetovaSaule K. Balmagambetova
Saule K. Balmagambetova
YBYerbol Z Bekmukhambetov
Yerbol Z Bekmukhambetov
ATAnar B Tulyaeva
Anar B Tulyaeva
YIYerbolat Maratovich Iztleuov
Yerbolat Maratovich Iztleuov
GSGaziza A Smagulova
Gaziza A Smagulova
IKIrakli Kokhreidze
Irakli Kokhreidze
Objective: to assess the current state of gastric cancer (GC) incidence and its five-year survival across Aktobe region of western Kazakhstan from 2009 to 2018 by presenting key indicators and analyzing the most significant features. Methods: Rough incidence rates (per 100,000) and average annual percent changes (aAPCs) were estimated for each age group at diagnosis with respect to gender, ethnicity, residence, the disease stages, tumor subsite, and histology type using linear regression analysis, including the prognostic index for 2019-2020. Overall five-year survival rates were estimated by the Kaplan-Meier method. Results: Overall GC incidence increased from 19.2 to 29.3, and averaged 25.8 (R2 0.65) with aAPC of 3.2%, with a potential to further rise (30.4 by 2020, p<0.001). Non-cardia location (17.8, p<0.001, aAPC 6.4%) and intestinal type of the tumor (17.0, p<0.001, aAPC 7.35%) were predominant. The observed overall five-year survival rate was 28.4% (95% CI 24.5;32.3) with a median survival time of 8.0 months (95% CI 6.6;9.4). Groups aged 40-49 and ≥70 had the lowest rates (24.4% and 22.1%, respectively, log-rank p 0.008), but the youngest individuals (18-39 years) showed the shortest median survival time, 5.0 months after diagnosis at the survival rate of 29.4%. Resectional surgery contributed significantly to the median survival time, 23.0 months vs. 6.0 in non-operated patients (log-rank p<0.001). Conclusion: GC in Aktobe region was featured by growing incidence and unsatisfactory five-year survival rates. Indigenous males of 60-69 years old with intestinal histology type, as well as the youngest patients irrespective of their gender, ethnicity, and other characteristics were recognized as high risk groups. Besides, relatively high aAPC 5.1% in the youngest revealed their further expected vulnerability. Further research is suggested to focus on risk factors, including gene expression profiling, to find out an accessible preventive strategy.

23 April 2024 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
ABAigerim Aldiyarovna Balapasheva
Aigerim Aldiyarovna Balapasheva
AMAigul Zakarievna Mussina
Aigul Zakarievna Mussina
GSGaziza Azhmagievna Smagulova
Gaziza Azhmagievna Smagulova
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
Aim: The study aimed to analyze the frequency and structure of antibacterial drug consumption during the COVID-19 pandemic at a dispensary hospital in Aktobe, Kazakhstan. It sought to identify the most frequently used and most costly antibacterial drugs, assessing their economic impact and usage patterns. Methods: This descriptive, retrospective clinical, economic, and pharmacoepidemiological study was conducted using data from the dispensary hospital's pharmacy and patient records between March 13, 2020, and December 31, 2020. The ABC/VEN analysis and ATC/DDD methodology were applied to evaluate the consumption of antibacterial drugs. Antibiotics were classified according to WHO AWARe criteria. Results: The study found that 27 different antibacterial drugs were used, representing 2.2% of all medications. The ABC/VEN analysis revealed that the majority of the budget was spent on a few high-cost drugs. Ceftriaxone was the most commonly used antibiotic, with a significant financial impact. According to the WHO AWaRe classification, most antibiotics fell into the Access and Watch categories. Conclusion: The study highlights a high rate of antibacterial drug usage, with significant financial implications for the hospital. The predominance of certain high-cost antibiotics, like ceftriaxone, indicates a need for more rational and cost-effective use of these medications. The findings call for improved adherence to clinical guidelines, enhanced education for medical professionals, and optimized antibiotic utilization to prevent resistance development and ensure better patient outcomes, especially in pandemic situations.

27 February 2026 in Наука и здравоохранение
Verified
Journal Article
Open access
PDF file
IKIndira Kaibagarova
Indira Kaibagarova
NANurgul Ablakimova
Nurgul Ablakimova
GSGaziza Smagulova
Gaziza Smagulova
NMNadiya Mavlyudova
Nadiya Mavlyudova
AMAigul Mussina
Aigul Mussina
LZLazzat Zhamaliyeva
Lazzat Zhamaliyeva
Background. Type 2 diabetes mellitus remains one of the leading causes of chronic morbidity and disability, imposing a substantial clinical and economic burden on healthcare systems. In primary health care settings, effective glycemic control largely depends on the rational prescribing of oral hypoglycemic agents, appropriate dosing, and patient adherence to therapy. However, real-world clinical practice often demonstrates deviations of prescribed daily doses from recommended standards, along with persistent barriers related to drug accessibility and financial constraints. This highlights the need to analyze the structure of oral hypoglycemic drug utilization and the factors influencing the achievement of target glycemic outcomes. Aim:to analyze the consumption patterns and therapeutic effectiveness of oral hypoglycemic drugs (OHDs) among patients with T2DM in the primary healthcare system of Aktobe, Kazakhstan, while identifying indirect indicators and possible barriers to glycemic control based on prescription patterns and dosage data. Materials and methods: Data from 386 T2DM patients receiving continuous OHD therapy for at least six months were extracted from the Medical Information System. The analysis focused on drug consumption patterns, defined daily dose (DDD) versus prescribed daily dose (PDD), glycemic outcomes, and comorbidities. HbA1c levels were evaluated to assess treatment effectiveness, while factors influencing therapy adherence and dosing were explored. Results: Metformin was the most prescribed monotherapy (31.9%), and a combination of sulfonylureas and metformin dominated dual therapy (41.7%). Combination therapy was necessary for 59.1% of patients, indicating the limitations of monotherapy in con-trolling glycemia. Combination therapies involving metformin significantly improved HbA1c levels, especially with sulfonylureas (61%, p = 0.003) and SGLT-2 inhibitors (70.5%, p = 0.039). However, the PDDs of all OHDs were markedly below the WHO DDDs, with metformin's PDD 78% lower. Barriers included medication access and financial constraints. Conclusions: Optimizing OHD regimens and addressing medication access challenges are essential to improving glycemic control and reducing T2DM complications in resource-constrained environments. Актуальность: Сахарный диабет 2 типа остается одной из ведущих причин хронической заболеваемости и инвалидизации, формируя значительную клиническую и экономическую нагрузку на систему здравоохранения. В условиях первичной медико-санитарной помощи эффективность контроля гликемии во многом зависит от рационального назначения пероральных сахароснижающих препаратов, адекватности их дозирования и приверженности пациентов терапии. Однако в реальной клинической практике часто наблюдаются отклонения предписанных суточных доз от рекомендованных стандартов, а также сохраняются барьеры, связанные с доступностью лекарств и финансовыми ограничениями. Это определяет необходимость анализа структуры потребления ПССП и факторов, влияющих на достижение целевых показателей гликемии. Цель: Изучение структуры потребления и терапевтической эффективности пероральных сахароснижающих препаратов (ПССП) у пациентов с сахарным диабетом 2 типа (СД2) в системе первичной медико-санитарной помощи г. Актобе, Казахстан, а также выявление факторов, препятствующих достижению оптимального контроля гликемии. Методы: Из медицинской информационной системы были извлечены данные о 386 пациентах с СД2, получавших непрерывную терапию ПССП в течение не менее шести месяцев. Анализ был сосредоточен на структуре потребления лекарств, сравнении определенной суточной дозы (DDD) с предписанной суточной дозой (PDD), гликемических показателях и сопутствующих заболеваниях. Эффективность лечения оценивалась по уровню HbA1c, а также изучались факторы, влияющие на приверженность терапии и дозирование. Результаты:Метформин был наиболее часто назначаемым препаратом в монотерапии (31,9%), тогда как комбинация метформина с препаратами сульфонилмочевины преобладала в двойной терапии (41,7%). Комбинированная терапия применялась у 59,1% пациентов, что указывает на ограниченную эффективность монотерапии в контроле гликемии. Комбинированная терапия с использованием метформина значительно снижала уровень HbA1c, особенно при сочетании с...